nucleocapsid.png

MicroGenDX COVID-19 Test Anticipates Coronavirus Mutations

The MicroGenDX PCR Test:

  • Remains effective for UK, South Africa, Brazil variants

  • Over 800,000 samples processed

  • 24-48 hour turnaround time

Many rapid PCR tests for SARS-CoV-2 may not be able to reliably detect the new variants from the UK, South Africa, and Brazil. The real-time reverse transcription PCR (rRT-qPCR) COVID-19 test from MicroGenDX can detect these variants.

In the latest SARS-CoV-2 strains, a majority of mutations are located in the spike protein (S) gene. MicroGenDX chose nucleocapsid protein (N) gene targets for its COVID-19 test in part because mutations are three times more likely to occur in the spike protein (S) gene of the virus.

As a result, MicroGenDX’s COVID-19 test is just as accurate in detecting new variants with spike protein (S) gene mutations as it is in detecting the original SARS-CoV-2 strain.